Stay updated on Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial
Sign up to get notified when there's something new on the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page.

Latest updates to the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedFooter revision tag updated from v3.3.1 to v3.3.2; no other visible content changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedSite revision updated from v3.2.0 to v3.3.1; no impact on study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedThe government funding/status notice on the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check43 days agoChange DetectedNon-significant changes observed: the page shows a new last update date (2025-06-26) and minor layout/text adjustments, with no changes to study design, eligibility criteria, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference3%

- Check79 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page.